Tracy R Daniels

Title: Tracy R Daniels: Innovator in Cancer Treatment

Introduction

Tracy R Daniels is a notable inventor based in Woodland Hills, CA (US). He has made significant contributions to the field of cancer treatment through his innovative research and development of monoclonal IgE antibodies.

Latest Patents

Daniels holds a patent for "IgE antibodies for the treatment of cancer." This invention provides monoclonal IgE antibodies that comprise Fc epsilon constant regions and variable regions with at least one antigen binding region. These antibodies are specifically designed to bind to a single epitope of a circulating, tumor-associated antigen (TAA) that is not a cell surface antigen. The targeted epitope is characterized as not being highly repetitive or as a non-repetitive epitope. The IgE antibodies developed by Daniels are particularly useful in treating cancers associated with tumor antigens, such as prostate-specific antigen (PSA).

Career Highlights

Throughout his career, Tracy R Daniels has worked with various organizations, including Quest Pharmatech, Inc. and the University of California. His work has focused on advancing the understanding and treatment of cancer through innovative antibody therapies.

Collaborations

Daniels has collaborated with notable colleagues, including Manuel L Penichet and Birgit Corinna Schultes, who have contributed to his research endeavors.

Conclusion

Tracy R Daniels is a pioneering inventor whose work in developing IgE antibodies represents a significant advancement in cancer treatment. His contributions continue to impact the field and offer hope for improved therapeutic options.